Insights

Cannabis oil could be used to treat insomnia after Perth trial

Published by External Author,
26, May

A world-first human trial in Perth could lead to medicinal cannabis being used to treat insomnia in Australia by the end of the year.

Stock image. Credit: Olichel/Pixabay

A world-first human trial in Perth could lead to medicinal cannabis being used to treat insomnia in Australia by the end of the year.

That’s the hope of WA-based Zelira Therapeutics, whose cannabis oil to treat insomnia will be available in the second half of 2020.

The company this week signed an exclusive manufacturing agreement with Tasmania Alkaloids to produce its insomnia product, ZLT-101.

This follows a successful world-first human trial at UWA’s Centre for Sleep Science that involved 23 patients diagnosed with chronic insomnia.

They were treated for 14 nights with ZLT-101 and for 14 nights with a placebo, with a week-long ‘washout’ period in between.

Participants using ZLT-101 reported longer, deeper sleep as well as better quality of life, meaning they felt rested after sleep and were less stressed and fatigued.

Read the full article by Perth Now on this exciting clinical trial: https://www.perthnow.com.au/community-news/western-suburbs-weekly/cannabis-oil-could-be-used-to-treat-insomnia-after-perth-trial-c-1060349